Results 201 to 210 of about 16,806 (319)

Immunoglobulin Components of "Gamma" Globulin in Human Serum [PDF]

open access: bronze, 1965
Virginia Trevorrow   +2 more
openalex   +1 more source

Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 10, Page 2854-2864, October 2025.
Abstract Aims Prednisone is a widely used glucocorticoid in the treatment of lupus, although its dosing is often determined empirically. Prednisolone, the active metabolite of prednisone, is found in its free form in the serum. The goal of this study was to develop a population pharmacokinetic model in patients with systemic lupus erythematosus (SLE ...
Naïm Bouazza   +26 more
wiley   +1 more source

Prediction of Lung Cancer Metastasis Using Machine Learning Models Based on Clinical Laboratory Data

open access: yesCancer Reports, Volume 8, Issue 10, October 2025.
ABSTRACT Background Lymph node (N) or/and distant metastasis in lung cancer indicates poorer prognosis. While laboratory tests and computed tomography (CT) scans reflect tumor growth and metabolic activity, they usually require combination with other diagnostic methods to effectively assess metastasis, resulting in limited clinical use of these results.
Chao Du   +6 more
wiley   +1 more source

Vaccination of Infants with Living Attenuated Measles Vaccine (Edmonston Strain) with and without Gamma-globulin [PDF]

open access: bronze, 1964
P. F. Benson   +6 more
openalex   +1 more source

Autoimmune Type 1 Diabetes in the Era of Disease‐Modifying Immune Therapy

open access: yesDiabetes/Metabolism Research and Reviews, Volume 41, Issue 7, October 2025.
While disease‐modifying therapies (DMTs) have been used to treat autoimmune diseases for decades, until recently, DMTs had not been used to treat autoimmune type 1 diabetes (T1D). The approval of the first DMT for use in individuals with preclinical T1D, teplizumab, has ushered in a new era in which healthcare providers can slow the T1D disease course.
Aaron W. Michels   +3 more
wiley   +1 more source

Hypergammaglobulinemia in Hidradenitis Suppurativa Patients: A New Emerging Association. [PDF]

open access: yesClin Cosmet Investig Dermatol
Martora F   +4 more
europepmc   +1 more source

Gamma Globulin for Measles

open access: yesAmerican Journal of Public Health and the Nations Health, 1945
openaire   +3 more sources

Effect of Gamma Globulin on Measles [PDF]

open access: yesPublic Health Reports (1896-1970), 1955
Harold M. Sterling   +2 more
openaire   +3 more sources

Are We Ready With Prevention for Type 1 Diabetes?

open access: yesDiabetes/Metabolism Research and Reviews, Volume 41, Issue 7, October 2025.
ABSTRACT Definitive prevention for type 1 diabetes (T1D) is not yet available, but we are now entering a new era where disease‐modifying therapies are becoming available in T1D to halt disease progression. In this review, we present up‐to‐date knowledge related to the prevention of T1D in youth, involving disease‐modifying therapies at different T1D ...
Evelina Maines   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy